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Dear Editor, 
We read with great interest the article with the title “Post-operative Brugada electrocardiographic 
pattern, polymorphic ventricular tachycardia, and sudden death in a child after administration of 
propofol anaesthesia”.1 They alluded that a fatal ventricular arrhythmia was induced by propofol in 
a patient with Brugada syndrome. Imputability analysis can be done using different methods, 
including expert judgement, the World Health Organisation, or another algorithmic method.2,3 
Concerning the expert judgement, it is crucial to understand what the actual cause of 
unresponsiveness was. Hypoxia, due to obstructive airway, respiratory depression, or both, rather 
than a primary arrhythmia, could be a culprit. Naloxone administration implies opioid overdose with 
symptoms of respiratory and consciousness deterioration. Due to its shorter duration of action than 
morphine, reoccurrence of the initial symptoms is a caveat. Accordingly, the American Academy of 
Otolaryngology – Head and Neck Surgery Foundation strongly recommends against administering or 
prescribing codeine after tonsillectomy in children younger than 12 years.4 This child received 
morphine. Besides, post-adenotonsillectomy haemorrhage is a well-known severe complication that 
might initially have caused or contributed to an obstructive airway5 but may have played a role 
when disseminated intravascular coagulopathy was presumed. 
Although the report states that at least 12 minutes elapsed before resuscitation, the total time of 
unresponsiveness and hypoxia remain unclear. The electrocardiographic pattern, as already 
described in cases of Brugada syndrome phenocopy,6 could be related to myocardial ischaemia, 
which was supported by the echocardiographic findings. Another potential trigger not excluded is 
electrolyte imbalance. 
If the electrocardiogram was a diagnostic finding of an unidentified Brugada syndrome, one might 
wonder why a single propofol dose induced a malignant arrhythmia only almost 6 hours later. From 
a pharmacokinetic point of view, this seems very unlikely. 
Though afebrile during hospitalisation, it is plausible that post-operative fever was developing when 
discharged. Fever, an altered autonomic state (abolishment of the adrenergic drive post-operatively, 
or by falling asleep in the car) in patients with Brugada syndrome, has been reported to trigger 
malignant arrhythmias.7 
Causality assessment for propofol according to the structured expert judgement method is 
considered as “Unlikely” because of the time to drug intake makes a relationship improbable and 
disease or other drugs provide plausible explanations. When using Kramer’s algorithm – one of the 
best-performing methods in the literature – causality is also categorised as “Unlikely” because of no 
dose-dependent relationship and other conditions potentially clarifying the event. Finally, we did not 
include propofol infusion syndrome in the structured imputability analysis, since one dose of 
propofol was administered.8,9  
Concluding, we also support a 12-lead preoperative screening, in a subset of children. Nevertheless, 
the conclusion of “a small risk of fatal ventricular arrhythmias in the post-operative period in 
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